Roche Tissue Diagnostics (Ventana Medical Systems)
Roche Tissue Diagnostics (Ventana Medical Systems) is recorded as a service provider in 2 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 2 of 2 trials · Latest update first
A Phase 3, Multicenter, Open-label, Randomized Study to Compare the Efficacy and Safety of MK-2870 Versus Treatment of Physician’s Choice in 3L+ Advanced/Metastatic Gastroesophageal Adenocarcinoma (Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, and Esophageal Adenocarcinoma)
Sponsor Merck Sharp & Dohme LLC
- Start (EU)
- Latest update
- Estimated end
AndroMETa-CRC-064: An Open Label, Randomized, Controlled, Global Phase 3 Study Comparing Telisotuzumab Adizutecan (ABBV-400) Monotherapy to LONSURF (Trifluridine and Tipiracil) plus Bevacizumab in Subjects with Refractory Metastatic Colorectal Cancer Expressing c-Met Protein Level Above a Defined Cutoff
Sponsor AbbVie Deutschland GmbH & Co. KG
- Start (EU)
- Not reported
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Roche Tissue Diagnostics (Ventana Medical Systems)?
The 2026-10-09 snapshot links Roche Tissue Diagnostics (Ventana Medical Systems) to 2 distinct CTIS trials. Recorded services include Laboratory services. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Roche Tissue Diagnostics (Ventana Medical Systems)?
The most frequently recorded therapeutic areas are Gastroenterology, Solid Tumor Oncology. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Roche Tissue Diagnostics (Ventana Medical Systems) conducted?
The linked trials record locations in 8 countries, including Germany, Spain, France, Italy, Poland. These are trial locations, not confirmed office locations or countries where Roche Tissue Diagnostics (Ventana Medical Systems) delivered services.
What can this page tell me about Roche Tissue Diagnostics (Ventana Medical Systems)'s trial experience?
Browse 2 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Roche Tissue Diagnostics (Ventana Medical Systems). Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Roche Tissue Diagnostics (Ventana Medical Systems)